Biotricity Inc. (“Biotricity) today announced its financial results for the third quarter of fiscal 2024 year and (unaudited) ended December 31, 2023. Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, “This quarter was marked by record margins, lowered costs and increasing revenues, supporting our path towards positive cashflow. The major theme for us was on long-term building- which meant reshaping our sales force to focus on efficiencies, longer sales cycles, larger accounts and independent hospitals and Group Purchasing Organizations- the necessary steps towards establishing recurring technology subscriptions and long-term growth.
